Tone Ikdahl

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 527 citations

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer

Anita Langerød, Hongjuan Zhao, Ørnulf Borgan et al. · Breast Cancer Research · 2007 · 292 citations · Full text

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

Elizabeth Poplin, Harpreet Wasan, Lindsey Rolfe et al. · Journal of Clinical Oncology · 2013 · 157 citations · Full text

Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing

Julian Hamfjord, Astrid M. Stangeland, Timothy Hughes et al. · PLoS ONE · 2012 · 155 citations · Full text

Engineering, Pathology, Transcriptomics Technology +20

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment

Janne B Kjersem, Tone Ikdahl, Tormod Kyrre Guren et al. · Molecular Oncology · 2013 · 143 citations · Full text